-

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Kyverna Therapeutics, Inc. (KYTX) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQ: KYTX) investors concerning the Company’s possible violations of federal securities laws.

On or about February 8, 2024, Kyverna conducted its initial public offering (“IPO”), selling 14.5 million shares of common stock for $22.00 per share.

On June 14, 2024, Kyverna provided an update on its lupus nephritis drug, KYV-101, and published an investor presentation disclosing adverse data regarding one of its clinical trials, despite having previously touted patient improvement.

Investors have suffered significant losses since the IPO.

If you purchased Kyverna securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Howard G. Smith, Esquire, of Law Offices of Howard G. Smith, 3070 Bristol Pike, Suite 112, Bensalem, Pennsylvania 19020 by telephone at (215) 638-4847 or by email to howardsmith@howardsmithlaw.com, or visit our website at www.howardsmithlaw.com.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

Industry:

Law Offices of Howard G. Smith

NASDAQ:KYTX
Release Versions
English

Contacts

Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
howardsmith@howardsmithlaw.com
www.howardsmithlaw.com

More News From Law Offices of Howard G. Smith

Securities Fraud Class Action Lawsuit Pending Against D-Wave Quantum, Inc.: The Law Offices of Howard G. Smith Highlights Lead Plaintiff Deadline

BENSALEM, Pa.--(BUSINESS WIRE)--D-Wave Quantum, Inc. ("D-Wave" or the "Company") (NASDAQ: QBTS) is the subject of a securities fraud class action lawsuit filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 26, 2026 through August 25, 2026, inclusive. The Law Offices of Howard G. Smith today reported the lawsuit, Fessler v. D-Wave Quantum, Inc. et al., which was filed on October 15, 2026 in the U.S. District Court California Northern District (C...

Deadline Alert: Millrose Properties, Inc. Stockholders Face December 8, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--Millrose Properties, Inc. ("Millrose" or the "Company") (NYSE: MRP) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 8, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 7, 2025 through October 2, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Rubenstsein et al. v....

Deadline Alert: The Chemours Company Stockholders Face December 7, 2026 Lead Plaintiff Deadline in Securities Fraud Class Action, The Law Offices of Howard G. Smith Highlights

BENSALEM, Pa.--(BUSINESS WIRE)--The Chemours Company ("Chemours" or the "Company") (NYSE: CC) investors who wish to serve as lead plaintiff in a pending securities fraud class action lawsuit must move the Court by December 7, 2026. The suit was filed on behalf of investors who purchased or otherwise acquired the Company's securities from February 20, 2026 through August 4, 2026, inclusive. The Law Offices of Howard G. Smith today highlighted the deadline in the case, Darcy v. The Chemours Compan...
Back to Newsroom